Skip to content
Health

Health Authorities Raise Alert Amid Rising Mpox Cases in Brazil and Argentina

Sanitary officials are reinforcing surveillance and monitoring travel-heavy regions following a notable increase in infections and the presence of the more contagious clado Ib strain.

By 3 min read

Health authorities across South America are closely monitoring a significant increase in mpox infections, formerly known as monkeypox, driven largely by a growing number of cases in Brazil. The Brazilian Ministry of Health reported a total of 832 confirmed infections so far this year, with substantial concentrations in major metropolitan areas including São Paulo, Rio de Janeiro, Ceará, and Brasília.

The outbreak in Brazil has alarmed regional health officials due to the accelerated transmission rate in specific cities. In São Paulo, authorities recorded 64 new cases over the course of a single month, while Rio de Janeiro detected 74 cases in just two months—a figure seven times higher than the total registered during the same period in the previous year. In response, the Brazilian government has reinforced epidemiological surveillance and secured 25,000 additional doses of the vaccine specifically allocated for designated risk groups.

Meanwhile, Argentina has reported 23 cases throughout the year, averaging roughly one new diagnosis per week. However, health officials remain cautious because at least four of these cases involve the clado Ib variant, which was first detected in the Democratic Republic of the Congo. Experts note that this specific strain is recognized as the most readily transmissible between people, with detections confirmed in Córdoba, San Juan, and the province of Buenos Aires.

The ongoing movement of travelers between neighboring countries has heightened vigilance. Medical experts emphasize that constant cross-border travel—accentuated by major regional events, international tourism, and the upcoming summer vacation season—underscores the need for heightened awareness among travelers regarding potential exposure risks.

Medical professionals describe mpox as a zoonotic viral infection that primarily spreads through close physical contact. Transmission frequently occurs skin-to-skin, face-to-face, or through intimate and sexual contact, even when penetration does not occur or condoms are used. The virus can also pass through respiratory droplets during prolonged close contact, or via contaminated personal items such as clothing, towels, and bedding.

Infectiologist Eduardo López explained that the infection typically begins with influenza-like symptoms, including high fever, severe headache, muscle aches, and swollen lymph nodes, before characteristic skin lesions or rashes develop across the body. The incubation period generally ranges from 6 to 20 days, and medical professionals advise early evaluation to ensure prompt isolation and appropriate clinical management.

Health agencies continue to stress that mass vaccination is not currently recommended for the general population. Instead, immunization efforts and antiviral treatments are specifically targeted toward high-risk groups, individuals with compromised immune systems, and those experiencing direct exposure to confirmed cases.

Sources

Related stories